Table 3 Summary of proposed protocol changes
Number | Summary |
|---|---|
1 | Inclusion of multiple recruitment and data collection sites |
2 | Inclusion of participants with COPD and asthma-COPD overlap (ACO) |
3 | Recruitment via general practitioner networks and professional recruitment companies |
4 | Screen participants for erythrocyte omega-3 index rather than self-report PUFA supplementation |